Cargando…
STM2457 Inhibits the Invasion and Metastasis of Pancreatic Cancer by Down-Regulating BRAF-Activated Noncoding RNA N6-Methyladenosine Modification
Pancreatic cancer is a malignant tumor of the digestive system that is highly malignant, difficult to treat, and confers a poor prognosis for patients. BRAF-activated noncoding RNA (BANCR) has been proven to play an important role in the invasion and metastasis of pancreatic cancer. In this study, w...
Autores principales: | Hao, Shaolong, Sun, Haitao, Sun, Hao, Zhang, Bo, Ji, Kailun, Liu, Peng, Nie, Fang, Han, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670688/ https://www.ncbi.nlm.nih.gov/pubmed/37998732 http://dx.doi.org/10.3390/cimb45110555 |
Ejemplares similares
-
METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome
por: Shi, Weili, et al.
Publicado: (2021) -
N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022) -
N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
por: Zhang, Zhongyuan, et al.
Publicado: (2021) -
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022) -
N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)